Upcoming Virtual Series: Case-Based Learning Collaborative on Stimulants (starts Oct. 20, 2023)
Posted September 28, 2023The Center for Behavioral and Addiction Medicine (CBAM) at the UCLA Department of Family Medicine is pleased to announce an upcoming virtual series, Case-Based Learning Collaborative on Stimulants. The series will be held biweekly on the first and third Fridays of the month from 12:00pm – 1:00pm PT, beginning Friday, October 20, 2023.
The learning objectives for this series include:
- To use a case-based learning approach to share experiences, educate, and disseminate the latest evidence-based data on the use of medications and other therapies for treating stimulant use disorders.
- To generate a network of providers and provide a reliable forum to discuss stimulant use disorders and their treatment.
- To present current evidence for treatment of stimulant use disorders to guide treatment decisions and to destigmatize treatment.
Physicians, nurses, physician associates, psychologists, social workers, recovery specialists, community health workers, students and anyone interested in improving the care of persons with stimulant use disorders are encouraged to join.
Credit Designation Statement
The David Geffen School of Medicine at UCLA designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
Upcoming 2023 topics:
- Friday, October 20, 2023 – Medications with Evidence for Stimulant Use Disorder presented by Dr. Steve Shoptaw, UCLA
- Friday, November 3, 2023 – MSM and Other Sexual Minority Identities, Infectious diseases, and Stimulants presented by Dr. Jesse Clark, UCLA
- Friday, November 17, 2023 – Infrastructure for Treating Stimulant Use in Primary Care Settingspresented by Dr. Brian Hurley, LA County Department of Public Health
- Friday, December 1, 2023 – Contingency Management, and Stimulant Use Disorder presented by Dr. DePhilipis, US Dept. of Veterans Affairs
Click here to join the listserv for this series. Please share the announcement with your colleagues and networks!
Contact Damilola Jolayemi at ojolayemi@mednet.ucla.edu with any questions.
UCLA HEALTH SCIENCES IMPORTANT WARNING: This email (and any attachments) is only intended for the use of the person or entity to which it is addressed, and may contain information that is privileged and confidential. You, the recipient, are obligated to maintain it in a safe, secure and confidential manner. Unauthorized redisclosure or failure to maintain confidentiality may subject you to federal and state penalties. If you are not the intended recipient, please immediately notify us by return email, and delete this message from your computer.
